Trailing-twelve-month (TTM) revenue is $42.55 Billion with a year-over-year growth of +8.93%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $10,845,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-24 |
| Q4 FY2025Period ended 2025-12-31 | $10,362,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q1 FY2026Period ended 2026-03-31 | $10,146,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-24 |
| Q2 FY2026Period ended 2026-06-30 | $11,192,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-24 |
| TTM revenue | $42,545,000,000 |
Current P/S: $296,884,032,800 market capitalization ÷ $42,545,000,000 TTM revenue = 6.98x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $11.19B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:16:02.700Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Combustible Products | $21.9B | $22.2B | $21.6B | $22.3B | $23.2B | $23.8B |
| Reduced-Risk Products | $6.8B | $9.1B | $10.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas Segment | N/A | $1.8B | $1.9B | $1.9B | $4.5B | $4.9B |
| EA, AU & PMI GTR Segment | N/A | N/A | N/A |
$42.55B
$42.55 Billion
+8.93%
vs. $39.06B a year ago (TTM)
+7.19%
5 Year compound annual growth rate
1 Year
+8.93%
3 Year
+8.65%
5 Year
+7.19%
10 Year
+5.03%
15 Year
+2.66%
20 Year
(0.54%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $40.65B | +$2.77B | +7.31% |
| 2024 | $37.88B | +$2.70B | +7.69% |
| 2023 | $35.17B | +$3.41B | +10.74% |
| 2022 | $31.76B | +$357.00M | +1.14% |
| 2021 | $31.41B | +$2.71B | +9.45% |
| 2020 |
TTM Growth
+8.93%
3-Year CAGR
+8.65%
5-Year CAGR
+7.19%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-26T00:16:02.700Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $14.7B |
| $16.9B |
| N/A |
| N/A |
| $6.6B |
| East Asia And Australia | $5.4B | $6.0B | $5.1B | $6.2B | $6.4B | N/A |
|---|
| Eastern Europe Middle East And Africa | $3.1B | $3.3B | $3.9B | N/A | N/A | N/A |
|---|
| European Union | $14.1B | $15.8B | $15.8B | $13.6B | $15.4B | $17.1B |
|---|
| Latin America And Canada | $1.7B | N/A | N/A | N/A | N/A | N/A |
|---|
| South And Southeast Asia | $4.4B | $4.4B | $4.4B | N/A | N/A | N/A |
|---|
| SSEA, CIS & MEA Segment | N/A | N/A | N/A | $10.6B | $11.3B | $12.1B |
|---|
| Swedish Match AB Segment | N/A | N/A | N/A | $2.5B | N/A | N/A |
|---|
| Wellness and Healthcare Segment | N/A | N/A | N/A | $306M | N/A | N/A |
|---|
| $28.69B |
| ($1.11B) |
| (3.73%) |
| 2019 | $29.80B | +$180.00M | +0.61% |
| 2018 | $29.63B | +$877.00M | +3.05% |
| 2017 | $28.75B | +$2.06B | +7.73% |
| 2016 | $26.68B | ($109.00M) | (0.41%) |
